News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
379,108 Results
Type
Article (23025)
Company Profile (31)
Press Release (356047)
Multimedia
Podcasts (127)
Webinars (14)
Section
Business (118448)
Career Advice (1421)
Deals (17220)
Drug Delivery (73)
Drug Development (42029)
Employer Resources (95)
FDA (8736)
Job Trends (8358)
News (189039)
Policy (16986)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1465)
Academic (1)
Accelerated approval (24)
Adcomms (17)
Allergies (112)
Alliances (33063)
ALS (135)
Alzheimer's disease (1050)
Antibody-drug conjugate (ADC) (278)
Approvals (9074)
Artificial intelligence (442)
Autoimmune disease (176)
Automation (37)
Bankruptcy (156)
Best Places to Work (6963)
BIOSECURE Act (6)
Biosimilars (132)
Biotechnology (26)
Bladder cancer (127)
Brain cancer (38)
Breast cancer (470)
Cancer (3747)
Cardiovascular disease (310)
Career advice (1230)
Career pathing (33)
CAR-T (170)
CDC (28)
Celiac Disease (1)
Cell therapy (542)
Cervical cancer (30)
Clinical research (37035)
Collaboration (1529)
Company closure (2)
Compensation (342)
Complete response letters (33)
COVID-19 (1502)
CRISPR (69)
C-suite (570)
Cystic fibrosis (84)
Data (5247)
Decentralized trials (3)
Denatured (44)
Depression (96)
Dermatology (50)
Diabetes (391)
Diagnostics (3695)
Digital health (33)
Diversity (7)
Diversity, equity & inclusion (29)
Drug discovery (206)
Drug pricing (103)
Drug shortages (21)
Duchenne muscular dystrophy (182)
Earnings (58812)
Editorial (48)
Employer branding (12)
Employer resources (83)
Events (58165)
Executive appointments (589)
FDA (11112)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (10)
Frontotemporal dementia (27)
Funding (957)
Gene editing (144)
Generative AI (47)
Gene therapy (476)
GLP-1 (636)
Government (2383)
Grass and pollen (6)
Guidances (337)
Healthcare (10189)
HIV (59)
Huntington's disease (36)
IgA nephropathy (64)
Immunology and inflammation (162)
Immuno-oncology (61)
Indications (134)
Infectious disease (1692)
Inflammatory bowel disease (141)
Inflation Reduction Act (12)
Influenza (76)
Intellectual property (171)
Interviews (266)
IPO (8332)
IRA (30)
Job creations (1701)
Job search strategy (992)
JPM (44)
Kidney cancer (10)
Labor market (56)
Layoffs (256)
Leadership (32)
Legal (4379)
Liver cancer (51)
Longevity (19)
Lung cancer (508)
Lymphoma (299)
Machine learning (33)
Management (32)
Manufacturing (609)
MASH (133)
Medical device (6795)
Medtech (6850)
Mergers & acquisitions (9668)
Metabolic disorders (960)
mRNA (117)
Multiple sclerosis (130)
NASH (9)
Neurodegenerative disease (242)
Neuropsychiatric disorders (59)
Neuroscience (1964)
NextGen: Class of 2026 (3375)
Non-profit (2693)
Now hiring (11)
Obesity (418)
Opinion (209)
Ovarian cancer (118)
Pain (145)
Pancreatic cancer (173)
Parkinson's disease (218)
Partnered (21)
Patents (336)
Patient recruitment (331)
Peanut (32)
People (28142)
Pharmaceutical (9)
Pharmacy benefit managers (17)
Phase 1 (11114)
Phase 2 (15759)
Phase 3 (13208)
Pipeline (5828)
Policy (173)
Postmarket research (1630)
Preclinical (4891)
Press Release (31)
Prostate cancer (245)
Psychedelics (31)
Radiopharmaceuticals (194)
Rare diseases (669)
Real estate (2545)
Recruiting (37)
Regulatory (13332)
Reports (23)
Research institute (1373)
Resumes & cover letters (217)
Rett syndrome (24)
RNA editing (13)
RSV (53)
Schizophrenia (114)
Series A (173)
Series B (101)
Service/supplier (3)
Sickle cell disease (78)
Special edition (14)
Spinal muscular atrophy (81)
Sponsored (29)
Startups (1501)
State (1)
Stomach cancer (11)
Supply chain (64)
Tariffs (39)
The Weekly (82)
Vaccines (639)
Venture capital (56)
Weight loss (257)
Women's health (67)
Worklife (15)
Date
Last 7 days (459)
Last 30 days (1579)
Last 365 days (19064)
2026 (6732)
2025 (18937)
2024 (20118)
2023 (22132)
2022 (27910)
2021 (29699)
2020 (28994)
2019 (24957)
2018 (18447)
2017 (17390)
2016 (16929)
2015 (19262)
2014 (16192)
2013 (14163)
2012 (13979)
2011 (13397)
2010 (12645)
Location
Africa (547)
Alabama (64)
Alaska (4)
Arizona (147)
Arkansas (8)
Asia (22096)
Australia (3627)
California (7590)
Canada (2222)
China (788)
Colorado (357)
Connecticut (392)
Delaware (239)
Europe (52133)
Florida (1238)
Georgia (262)
Hawaii (1)
Idaho (24)
Illinois (593)
India (65)
Indiana (421)
Iowa (10)
Japan (348)
Kansas (75)
Kentucky (22)
Louisiana (14)
Maine (34)
Maryland (929)
Massachusetts (5496)
Michigan (225)
Minnesota (334)
Mississippi (2)
Missouri (66)
Montana (11)
Nebraska (9)
Nevada (87)
New Hampshire (37)
New Jersey (2419)
New Mexico (13)
New York (2134)
North Carolina (1009)
North Dakota (5)
Northern California (3732)
Ohio (197)
Oklahoma (16)
Oregon (19)
Pennsylvania (1640)
Puerto Rico (9)
Rhode Island (26)
South America (750)
South Carolina (34)
Southern California (3107)
Tennessee (145)
Texas (1217)
United States (27651)
Utah (252)
Vermont (1)
Virginia (175)
Washington D.C. (52)
Washington State (622)
West Virginia (2)
Wisconsin (66)
Wyoming (2)
379,108 Results for "hellman and friedman".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Blackstone, Carlyle and Hellman & Friedman to Invest in Medline
Medline Industries, Inc., the nation’s largest privately held manufacturer and distributor of healthcare supplies with 2020 revenue of $17.5 billion, announced that it has entered into a definitive agreement through which it will receive a majority investment from a partnership comprised of funds managed by Blackstone, Carlyle and Hellman & Friedman.
June 5, 2021
·
5 min read
Deals
Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman
Cardinal Health announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman for approximately $1 billion, which includes buyer’s assumption of certain liabilities and seller’s retention of certain working capital accounts.
March 12, 2021
·
6 min read
Business
Scorpion Therapeutics Appoints Adam Friedman, M.D., Ph.D., as Chief Executive Officer and Expands Leadership Team
Scorpion Therapeutics, Inc. announced leadership changes intended to position the Company for its next phase of growth, including the appointment of Adam Friedman, M.D., Ph.D., as Chief Executive Officer.
January 4, 2024
·
7 min read
Press Releases
Scott L. Friedman, MD, Joins HepaTx Scientific Advisory Board
November 25, 2024
·
1 min read
Business
NextRNA Therapeutics Strengthens Board of Directors with Appointment of Lori Friedman, PhD
NextRNA Therapeutics, a biotechnology company unlocking the potential of long non-coding RNAs (lncRNAs) to develop transformative medicines for multiple diseases with an initial focus on oncology and neurology, today announced the appointment of Lori Friedman, PhD, to its Board of Directors.
September 26, 2023
·
3 min read
Press Releases
Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby
April 8, 2026
·
4 min read
Business
Barrow Neurological Institute at Phoenix Children’s Appoints Neil Friedman, MBChB, as Director
Barrow Neurological Institute at Phoenix Children’s, one of the largest pediatric neuroscience programs in the country, announced the appointment of Neil Friedman, MBChB as director.
March 27, 2023
·
3 min read
Press Releases
Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters’ option to purchase additional shares
March 10, 2026
·
5 min read
Press Releases
Medline Inc. announces launch of secondary offering of Class A common stock
March 3, 2026
·
4 min read
Press Releases
Medline Inc. announces pricing of secondary offering of class A common stock
March 5, 2026
·
5 min read
1 of 37,911
Next